Cargando…
The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation
BACKGROUND: Human endogenous retroviruses (HERVs) constitute 8% of the human genome and contribute substantially to the transcriptome. HERVs have been shown to generate RNAs that modulate host gene expression. However, experimental evidence for an impact of these regulatory transcripts on the cellul...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142424/ https://www.ncbi.nlm.nih.gov/pubmed/27980690 http://dx.doi.org/10.1186/s13100-016-0081-9 |
_version_ | 1782472773829918720 |
---|---|
author | Broecker, Felix Horton, Roger Heinrich, Jochen Franz, Alexandra Schweiger, Michal-Ruth Lehrach, Hans Moelling, Karin |
author_facet | Broecker, Felix Horton, Roger Heinrich, Jochen Franz, Alexandra Schweiger, Michal-Ruth Lehrach, Hans Moelling, Karin |
author_sort | Broecker, Felix |
collection | PubMed |
description | BACKGROUND: Human endogenous retroviruses (HERVs) constitute 8% of the human genome and contribute substantially to the transcriptome. HERVs have been shown to generate RNAs that modulate host gene expression. However, experimental evidence for an impact of these regulatory transcripts on the cellular phenotype has been lacking. RESULTS: We characterized the previously little described HERV-K(HML-10) endogenous retrovirus family on a genome-wide scale. HML-10 invaded the ancestral genome of Old World monkeys about 35 Million years ago and is enriched within introns of human genes when compared to other HERV families. We show that long terminal repeats (LTRs) of HML-10 exhibit variable promoter activity in human cancer cell lines. One identified HML-10 LTR-primed RNA was in opposite orientation to the pro-apoptotic Death-associated protein 3 (DAP3). In HeLa cells, experimental inactivation of HML-10 LTR-primed transcripts induced DAP3 expression levels, which led to apoptosis. CONCLUSIONS: Its enrichment within introns suggests that HML-10 may have been evolutionary co-opted for gene regulation more than other HERV families. We demonstrated such a regulatory activity for an HML-10 RNA that suppressed DAP3-mediated apoptosis in HeLa cells. Since HML-10 RNA appears to be upregulated in various tumor cell lines and primary tumor samples, it may contribute to evasion of apoptosis in malignant cells. However, the overall weak expression of HML-10 transcripts described here raises the question whether our result described for HeLa represent a rare event in cancer. A possible function in other cells or tissues requires further investigation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13100-016-0081-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5142424 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-51424242016-12-15 The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation Broecker, Felix Horton, Roger Heinrich, Jochen Franz, Alexandra Schweiger, Michal-Ruth Lehrach, Hans Moelling, Karin Mob DNA Research BACKGROUND: Human endogenous retroviruses (HERVs) constitute 8% of the human genome and contribute substantially to the transcriptome. HERVs have been shown to generate RNAs that modulate host gene expression. However, experimental evidence for an impact of these regulatory transcripts on the cellular phenotype has been lacking. RESULTS: We characterized the previously little described HERV-K(HML-10) endogenous retrovirus family on a genome-wide scale. HML-10 invaded the ancestral genome of Old World monkeys about 35 Million years ago and is enriched within introns of human genes when compared to other HERV families. We show that long terminal repeats (LTRs) of HML-10 exhibit variable promoter activity in human cancer cell lines. One identified HML-10 LTR-primed RNA was in opposite orientation to the pro-apoptotic Death-associated protein 3 (DAP3). In HeLa cells, experimental inactivation of HML-10 LTR-primed transcripts induced DAP3 expression levels, which led to apoptosis. CONCLUSIONS: Its enrichment within introns suggests that HML-10 may have been evolutionary co-opted for gene regulation more than other HERV families. We demonstrated such a regulatory activity for an HML-10 RNA that suppressed DAP3-mediated apoptosis in HeLa cells. Since HML-10 RNA appears to be upregulated in various tumor cell lines and primary tumor samples, it may contribute to evasion of apoptosis in malignant cells. However, the overall weak expression of HML-10 transcripts described here raises the question whether our result described for HeLa represent a rare event in cancer. A possible function in other cells or tissues requires further investigation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13100-016-0081-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-12-07 /pmc/articles/PMC5142424/ /pubmed/27980690 http://dx.doi.org/10.1186/s13100-016-0081-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Broecker, Felix Horton, Roger Heinrich, Jochen Franz, Alexandra Schweiger, Michal-Ruth Lehrach, Hans Moelling, Karin The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation |
title | The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation |
title_full | The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation |
title_fullStr | The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation |
title_full_unstemmed | The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation |
title_short | The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation |
title_sort | intron-enriched herv-k(hml-10) family suppresses apoptosis, an indicator of malignant transformation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142424/ https://www.ncbi.nlm.nih.gov/pubmed/27980690 http://dx.doi.org/10.1186/s13100-016-0081-9 |
work_keys_str_mv | AT broeckerfelix theintronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation AT hortonroger theintronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation AT heinrichjochen theintronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation AT franzalexandra theintronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation AT schweigermichalruth theintronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation AT lehrachhans theintronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation AT moellingkarin theintronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation AT broeckerfelix intronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation AT hortonroger intronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation AT heinrichjochen intronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation AT franzalexandra intronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation AT schweigermichalruth intronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation AT lehrachhans intronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation AT moellingkarin intronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation |